Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Phloridzin docosahexaenoate, a novel fatty acid ester of a plant polyphenol, inhibits mammary carcinoma cell metastasis.

Fernando W, Coyle K, Marcato P, Vasantha Rupasinghe HP, Hoskin DW.

Cancer Lett. 2019 Aug 29;465:68-81. doi: 10.1016/j.canlet.2019.08.015. [Epub ahead of print]

PMID:
31473253
2.

Assessing the cytotoxic potential of glycoalkaloidic extract in nanoparticles against bladder cancer cells.

Miranda MA, Marcato PD, Carvalho IPS, Silva LB, Ribeiro DL, Amaral R, Swiech K, Bastos JK, Paschoal JAR, Dos Reis RB, Bentley MVLB.

J Pharm Pharmacol. 2019 Oct;71(10):1520-1531. doi: 10.1111/jphp.13145. Epub 2019 Aug 5.

PMID:
31385306
3.

Retinoic acid and arsenic trioxide induce lasting differentiation and demethylation of target genes in APL cells.

Huynh TT, Sultan M, Vidovic D, Dean CA, Cruickshank BM, Lee K, Loung CY, Holloway RW, Hoskin DW, Waisman DM, Weaver ICG, Marcato P.

Sci Rep. 2019 Jul 1;9(1):9414. doi: 10.1038/s41598-019-45982-7.

4.

ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.

Vidovic D, Huynh TT, Konda P, Dean C, Cruickshank BM, Sultan M, Coyle KM, Gujar S, Marcato P.

Cell Death Differ. 2019 Jun 13. doi: 10.1038/s41418-019-0362-1. [Epub ahead of print]

PMID:
31197235
5.

TRPM2 ion channel promotes gastric cancer migration, invasion and tumor growth through the AKT signaling pathway.

Almasi S, Sterea AM, Fernando W, Clements DR, Marcato P, Hoskin DW, Gujar S, El Hiani Y.

Sci Rep. 2019 Mar 12;9(1):4182. doi: 10.1038/s41598-019-40330-1.

6.

Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles.

Abriata JP, Turatti RC, Luiz MT, Raspantini GL, Tofani LB, do Amaral RLF, Swiech K, Marcato PD, Marchetti JM.

Mater Sci Eng C Mater Biol Appl. 2019 Mar;96:347-355. doi: 10.1016/j.msec.2018.11.035. Epub 2018 Nov 24.

PMID:
30606542
7.

TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem-Like Cells in a Redox-Sensitive Manner.

Sharif T, Dai C, Martell E, Ghassemi-Rad MS, Hanes MR, Murphy PJ, Kennedy BE, Venugopal C, Subapanditha M, Giacomantonio CA, Marcato P, Singh SK, Gujar S.

Clin Cancer Res. 2019 Mar 15;25(6):2001-2017. doi: 10.1158/1078-0432.CCR-17-3177. Epub 2018 Dec 28.

PMID:
30593514
8.

DNA Methylation Predicts the Response of Triple-Negative Breast Cancers to All-Trans Retinoic Acid.

Coyle KM, Dean CA, Thomas ML, Vidovic D, Giacomantonio CA, Helyer L, Marcato P.

Cancers (Basel). 2018 Oct 24;10(11). pii: E397. doi: 10.3390/cancers10110397.

9.

Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL).

Holloway RW, Thomas ML, Cohen AM, Bharadwaj AG, Rahman M, Marcato P, Marignani PA, Waisman DM.

Cell Death Dis. 2018 Sep 11;9(9):920. doi: 10.1038/s41419-018-0954-6.

10.

ALDH1A3 Is the Key Isoform That Contributes to Aldehyde Dehydrogenase Activity and Affects in Vitro Proliferation in Cardiac Atrial Appendage Progenitor Cells.

Puttini S, Plaisance I, Barile L, Cervio E, Milano G, Marcato P, Pedrazzini T, Vassalli G.

Front Cardiovasc Med. 2018 Jul 24;5:90. doi: 10.3389/fcvm.2018.00090. eCollection 2018.

11.

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.

Cruickshank B, Giacomantonio M, Marcato P, McFarland S, Pol J, Gujar S.

Front Immunol. 2018 Apr 3;9:654. doi: 10.3389/fimmu.2018.00654. eCollection 2018. Review.

12.

Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.

Thomas ML, Marcato P.

Cancers (Basel). 2018 Apr 1;10(4). pii: E101. doi: 10.3390/cancers10040101. Review.

13.

Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties.

Pivetta TP, Simões S, Araújo MM, Carvalho T, Arruda C, Marcato PD.

Colloids Surf B Biointerfaces. 2018 Apr 1;164:281-290. doi: 10.1016/j.colsurfb.2018.01.053. Epub 2018 Jan 31.

PMID:
29413607
14.

Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion.

Sultan M, Vidovic D, Paine AS, Huynh TT, Coyle KM, Thomas ML, Cruickshank BM, Dean CA, Clements DR, Kim Y, Lee K, Gujar SA, Weaver ICG, Marcato P.

Stem Cells. 2018 May;36(5):641-654. doi: 10.1002/stem.2780. Epub 2018 Jan 30.

15.

Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.

Coyle KM, Maxwell S, Thomas ML, Marcato P.

Sci Rep. 2017 Nov 30;7(1):16684. doi: 10.1038/s41598-017-16687-6.

16.

Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening.

Amaral RLF, Miranda M, Marcato PD, Swiech K.

Front Physiol. 2017 Aug 22;8:605. doi: 10.3389/fphys.2017.00605. eCollection 2017.

17.

Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.

Coyle KM, Boudreau JE, Marcato P.

Biomed Res Int. 2017;2017:9620870. doi: 10.1155/2017/9620870. Epub 2017 Jun 8. Review.

18.

Hide-and-seek: the interplay between cancer stem cells and the immune system.

Sultan M, Coyle KM, Vidovic D, Thomas ML, Gujar S, Marcato P.

Carcinogenesis. 2017 Feb 1;38(2):107-118. doi: 10.1093/carcin/bgw115. Review.

PMID:
27866156
19.

Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3.

Thomas ML, de Antueno R, Coyle KM, Sultan M, Cruickshank BM, Giacomantonio MA, Giacomantonio CA, Duncan R, Marcato P.

Mol Oncol. 2016 Nov;10(9):1485-1496. doi: 10.1016/j.molonc.2016.08.004. Epub 2016 Aug 25.

20.

Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1.

Coyle KM, Murphy JP, Vidovic D, Vaghar-Kashani A, Dean CA, Sultan M, Clements D, Wallace M, Thomas ML, Hundert A, Giacomantonio CA, Helyer L, Gujar SA, Lee PW, Weaver IC, Marcato P.

Oncotarget. 2016 Jul 12;7(28):44096-44112. doi: 10.18632/oncotarget.9858.

21.

The NAD(+) salvage pathway modulates cancer cell viability via p73.

Sharif T, Ahn DG, Liu RZ, Pringle E, Martell E, Dai C, Nunokawa A, Kwak M, Clements D, Murphy JP, Dean C, Marcato P, McCormick C, Godbout R, Gujar SA, Lee PW.

Cell Death Differ. 2016 Apr;23(4):669-80. doi: 10.1038/cdd.2015.134. Epub 2015 Nov 20.

22.

Polymeric Nanoparticles of Enoxaparin as a Delivery System: In Vivo Evaluation in Normal Rats and in a Venous Thrombosis Rat Model.

Pazzini C, Marcato PD, Prado LB, Alessio AM, Höehr NF, Montalvão S, Paixão D, Durán N, Annichino-Bizzacchi JM.

J Nanosci Nanotechnol. 2015 Jul;15(7):4837-43.

PMID:
26373044
23.

Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans.

Longhi C, Santos JP, Morey AT, Marcato PD, Durán N, Pinge-Filho P, Nakazato G, Yamada-Ogatta SF, Yamauchi LM.

Med Mycol. 2016 May;54(4):428-32. doi: 10.1093/mmy/myv036. Epub 2015 Jun 19.

PMID:
26092103
24.

A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations.

Canino C, Luo Y, Marcato P, Blandino G, Pass HI, Cioce M.

Oncotarget. 2015 May 20;6(14):12637-53.

25.

Newly recruited CD11b+, GR-1+, Ly6C(high) myeloid cells augment tumor-associated immunosuppression immediately following the therapeutic administration of oncolytic reovirus.

Clements DR, Sterea AM, Kim Y, Helson E, Dean CA, Nunokawa A, Coyle KM, Sharif T, Marcato P, Gujar SA, Lee PW.

J Immunol. 2015 May 1;194(9):4397-412. doi: 10.4049/jimmunol.1402132. Epub 2015 Mar 30.

26.

Reference values for high-density lipoprotein particle size and volume by dynamic light scattering in a Brazilian population sample and their relationships with metabolic parameters.

Alexandre F, Zago VH, Panzoldo NB, Parra ES, Scherrer DZ, Vendrame F, Nunes VS, Gomes EI, Marcato PD, Nakandakare ER, Quintão EC, de Faria EC.

Clin Chim Acta. 2015 Mar 10;442:63-72. doi: 10.1016/j.cca.2015.01.006. Epub 2015 Jan 14.

PMID:
25595435
27.

Preparation of an agar-silver nanoparticles (A-AgNp) film for increasing the shelf-life of fruits.

Gudadhe JA, Yadav A, Gade A, Marcato PD, Durán N, Rai M.

IET Nanobiotechnol. 2014 Dec;8(4):190-5. doi: 10.1049/iet-nbt.2013.0010.

PMID:
25429496
28.

Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.

Mathenge EG, Dean CA, Clements D, Vaghar-Kashani A, Photopoulos S, Coyle KM, Giacomantonio M, Malueth B, Nunokawa A, Jordan J, Lewis JD, Gujar SA, Marcato P, Lee PW, Giacomantonio CA.

Neoplasia. 2014 Nov 20;16(11):950-60. doi: 10.1016/j.neo.2014.09.004. eCollection 2014 Nov.

29.

Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: a prospective controlled study.

Pezzoli M, Magnano M, Maffi L, Pezzoli L, Marcato P, Orione M, Cupi D, Bongioannini G.

Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1659-66. doi: 10.1007/s00405-014-2948-z. Epub 2014 Oct 16.

PMID:
25318685
30.

Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.

Marcato P, Dean CA, Liu RZ, Coyle KM, Bydoun M, Wallace M, Clements D, Turner C, Mathenge EG, Gujar SA, Giacomantonio CA, Mackey JR, Godbout R, Lee PW.

Mol Oncol. 2015 Jan;9(1):17-31. doi: 10.1016/j.molonc.2014.07.010. Epub 2014 Jul 24.

31.

Cisplatin Properties in a Nanobiotechnological Approach to Cancer: A Mini-Review.

Marcato PD, Fávaro WJ, Durán N.

Curr Cancer Drug Targets. 2014;14(5):458-76. Review.

PMID:
24806969
32.

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms.

Gujar SA, Clements D, Dielschneider R, Helson E, Marcato P, Lee PW.

Br J Cancer. 2014 Jan 7;110(1):83-93. doi: 10.1038/bjc.2013.695. Epub 2013 Nov 26.

33.

Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis.

Pan D, Marcato P, Ahn DG, Gujar S, Pan LZ, Shmulevitz M, Lee PW.

PLoS One. 2013;8(1):e54006. doi: 10.1371/journal.pone.0054006. Epub 2013 Jan 16.

34.

Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation.

Gujar S, Dielschneider R, Clements D, Helson E, Shmulevitz M, Marcato P, Pan D, Pan LZ, Ahn DG, Alawadhi A, Lee PW.

Mol Ther. 2013 Feb;21(2):338-47. doi: 10.1038/mt.2012.228. Epub 2012 Nov 13.

35.

Biogenic antimicrobial silver nanoparticles produced by fungi.

Rodrigues AG, Ping LY, Marcato PD, Alves OL, Silva MC, Ruiz RC, Melo IS, Tasic L, De Souza AO.

Appl Microbiol Biotechnol. 2013 Jan;97(2):775-82. doi: 10.1007/s00253-012-4209-7. Epub 2012 Jun 16.

PMID:
22707055
36.

Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.

Ridolfi DM, Marcato PD, Justo GZ, Cordi L, Machado D, Durán N.

Colloids Surf B Biointerfaces. 2012 May 1;93:36-40. doi: 10.1016/j.colsurfb.2011.11.051. Epub 2011 Dec 17.

PMID:
22244299
37.

Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation.

Pan D, Pan LZ, Hill R, Marcato P, Shmulevitz M, Vassilev LT, Lee PW.

Br J Cancer. 2011 Sep 27;105(7):1012-22. doi: 10.1038/bjc.2011.325. Epub 2011 Aug 23.

38.

Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform.

Marcato P, Dean CA, Giacomantonio CA, Lee PW.

Cell Cycle. 2011 May 1;10(9):1378-84. Epub 2011 May 1. Review.

PMID:
21552008
39.

Mechanistic aspects in the biogenic synthesis of extracellular metal nanoparticles by peptides, bacteria, fungi, and plants.

Durán N, Marcato PD, Durán M, Yadav A, Gade A, Rai M.

Appl Microbiol Biotechnol. 2011 Jun;90(5):1609-24. doi: 10.1007/s00253-011-3249-8. Epub 2011 Apr 12. Review.

PMID:
21484205
40.

Nanostructured polymer and lipid carriers for sunscreen. Biological effects and skin permeation.

Marcato PD, Caverzan J, Rossi-Bergmann B, Pinto EF, Machado D, Silva RA, Justo GZ, Ferreira CV, Durán N.

J Nanosci Nanotechnol. 2011 Mar;11(3):1880-6.

PMID:
21449324
41.

Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.

Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PW.

Stem Cells. 2011 Jan;29(1):32-45. doi: 10.1002/stem.563.

42.

Oncolytic virus-initiated protective immunity against prostate cancer.

Gujar SA, Pan DA, Marcato P, Garant KA, Lee PW.

Mol Ther. 2011 Apr;19(4):797-804. doi: 10.1038/mt.2010.297. Epub 2011 Jan 18.

43.

Reovirus virotherapy overrides tumor antigen presentation evasion and promotes protective antitumor immunity.

Gujar SA, Marcato P, Pan D, Lee PW.

Mol Cancer Ther. 2010 Nov;9(11):2924-33. doi: 10.1158/1535-7163.MCT-10-0590. Epub 2010 Oct 26.

44.

Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO.

Vezzali E, Parodi AL, Marcato PS, Bettini G.

Vet Comp Oncol. 2010 Mar;8(1):38-49. doi: 10.1111/j.1476-5829.2009.00201.x.

PMID:
20230580
45.

Nanocytotoxicity: violacein and violacein-loaded poly (D, L-lactide-co-glycolide) nanoparticles acting on human leukemic cells.

Melo PS, De Azevedo MM, Frungillo L, Anazetti MC, Marcato PD, Duran N.

J Biomed Nanotechnol. 2009 Apr;5(2):192-201.

PMID:
20055097
46.

Association between environmental dust exposure and lung cancer in dogs.

Bettini G, Morini M, Marconato L, Marcato PS, Zini E.

Vet J. 2010 Dec;186(3):364-9. doi: 10.1016/j.tvjl.2009.09.004. Epub 2009 Dec 30.

PMID:
20044284
47.

Targeting cancer-initiating cells with oncolytic viruses.

Cripe TP, Wang PY, Marcato P, Mahller YY, Lee PW.

Mol Ther. 2009 Oct;17(10):1677-82. doi: 10.1038/mt.2009.193. Epub 2009 Aug 11. Review.

48.

If cancer stem cells are resistant to current therapies, what's next?

Marcato P, Dean CA, Giacomantonio CA, Lee PW.

Future Oncol. 2009 Aug;5(6):747-50. doi: 10.2217/fon.09.58. No abstract available.

49.

Activated Ras signaling significantly enhances reovirus replication and spread.

Shmulevitz M, Marcato P, Lee PW.

Cancer Gene Ther. 2010 Jan;17(1):69-70. doi: 10.1038/cgt.2009.46. No abstract available.

PMID:
19590528
50.

Oncolytic reovirus effectively targets breast cancer stem cells.

Marcato P, Dean CA, Giacomantonio CA, Lee PW.

Mol Ther. 2009 Jun;17(6):972-9. doi: 10.1038/mt.2009.58. Epub 2009 Mar 17.

Supplemental Content

Loading ...
Support Center